Valeant Settles One Legal Headache But Still Faces Congressional, DOJ Probes
This article was originally published in The Pink Sheet Daily
Executive Summary
Valeant gets payment from R&O Pharmacy in litigation settlement as House Oversight Committee presses firm to explain why it is withholding certain documents.
You may also be interested in...
Former Valeant, Philidor Execs Charged With Elaborate Kickback Scheme
Specialty mail-order pharmacy Philidor was held up as an example of how Valeant was bilking patients when the usually close arrangement initially came to light; now it seems that Valeant itself was allegedly getting bilked.
At Drug Pricing Hearing, Innovator Companies Mainly Escape Congressional Wrath
Members of House Oversight Committee accuse Turing and Valeant of 'trashing' mainstream innovator companies with their drug pricing practices.
Companies Reveal Hurdles In Providing Drugs Via Expanded Access Programs
GSK, Stealth BioTherapeutics and Blueprint Medicines discuss the difficulties getting participation of physicians, the excessive cost of expanded access, and whether physicians should report research data.